Home » Topics » BioWorld Science

BioWorld Science
RSS

Positive topline results presented from phase III study of contezolid in cSSTI

Sep. 20, 2019

PDS Biotechnology presents phase I data for its novel immunotherapy PDS-0101

Sep. 20, 2019

CinDome Pharma initiates phase II study of deuterated domperidone

Sep. 20, 2019

Researchers unveil the role of vasorin in angiogenesis and tumor progression in glioma

Sep. 20, 2019

Rare eye disease gives clues to peripheral neuropathy

Sep. 20, 2019

CAR relative CCR may offer targeting advantages

Sep. 20, 2019

Bone-deep stress

Sep. 20, 2019

Exosome-derived miRNAs from colon cancer cells promote fibroblast proliferation and tumor growth

Sep. 20, 2019

BeiGene studies BGB-A1217 with tislelizumab in advanced solid tumors

Sep. 19, 2019

Alzprotect cleared to begin French phase IIa trial of AZP-2006 in progressive supranuclear palsy

Sep. 19, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...